Voice of AmericaImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Voice of America File main menu
DonateNow
Print this Article


Jesuit AIDS Activist Criticizes Drug Companies, Calling Inaction On Drug Access Comparable To Genocide

Voice of America - January 30, 2004
Joe De Capua
Washington


Click to download/open (MP3)
Click to download/open (Real Audio)

Fr. D'Agostino
Fr. D'Agostino
The founder of an AIDS orphanage in Kenya says the lack of available treatment for the disease is comparable to “genocide.” Father Angelo D’Agostino spoke yesterday at the Vatican at a news conference on the Pope’s Lenten message. Father D’Agostino, founder of the Nyumbani home in Nairobi, accused pharmaceutical companies of “lacking a social conscience.”

Friday, English to Africa Joe De Capua spoke to the Jesuit priest and medical doctor as he drove through the city of Rome. He spoke about his comments at the Vatican on HIV/AIDS. He says he was at the Vatican to accept a gift on behalf of the Nyumbani orphanage. But says, “During the course of my remarks, I mentioned that we were still having trouble accessing anti-retroviral drugs in Africa to the extent that in Kenya there are at least 400 people dying every day. In all of Africa, probably 8,000 or 10,000.” He says despite the fact that the drug companies have said they are reducing prices, people are “still dying at an alarming rate.”

Father D’Agostino defends his use of the word genocide in describing the AIDS pandemic. He says nearly one million people died during the Rwanda genocide in 1994, while as many as 25 million people are at risk of dying needlessly because the drugs are not available. “If that isn’t genocide, I don’t know what you would call it,” he says.

The Roman Catholic priest recommends that drug companies lower their prices so they are on a par with the generic drugs produced in India. The Nyumbani orphanage has received free drugs from Brazil, which he says has saved the lives of many children.

Pharmaceutical companies say it costs hundreds of millions of dollars to research and develop new medicines; and if costs are not recouped, they would not be able to continue at the same level of R&D. A number of drug companies have lowered prices on some of their ARV's, anti-retrovirals. Father D’Agostino says the original AIDS fighting drugs were developed with US taxpayer money at Federal agencies and at universities.

Click above links to hear interview with Fr. Angelo D'Agostino.

040130
VA040112


Copyright © 2004 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .